Auro Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

263.00

+1.55 (+0.59%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

263.00

+1.55 (+0.59%)
09:53 Jan 03

Quality

70/100
High Financial Strength

Valuation

51/100
Affordable Valuation

Technical

61/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	54.25	50.87	52.89	53.64	38.86
Operating Expenses +	43	46.23	48.51	42.96	30.31
Raw Material	27.64	33.76	37.3	29.04	13.95
Increase Decrease in Cost	0.91	-0.98	-1.61	-2.48	1.9
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	6.04	6.24	4.72	5.14	5.49
Miscellaneous Expenses	8.83	7.25	8.1	11.26	8.97
Operating Profit	11.25	4.64	4.38	10.68	8.55
Other Income	0.76	1.09	0.94	1.5	1.33
Depreciation	1.04	1.02	1.07	1.09	1.09
Interest	0.46	0.83	0.81	0.74	0.65
Profit before tax and exceptio..	10.51	3.87	3.45	10.35	8.14
Exceptional Items	0	0	0	0	0
PBT	10.51	3.87	3.45	10.35	8.14
Provision for Taxation	3.33	1.03	1	2.55	1.95
Net Profit	7.18	2.84	2.44	7.79	6.16
NET Profit after MI	0	0	0	0	0
EPS	11.52	4.56	3.92	12.5	9.89
Operating Profit Margin (%)	20.74	9.12	8.28	19.91	22
Net Profit Margin (%)	13.24	5.58	4.61	14.52	15.85

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	52.20	52.20	52.20	52.10	52.10
FII	0.00	0.00	0.00	0.00	0.00
MF	0.00	0.00	0.00	0.00	0.00
Public	47.80	47.80	47.80	47.90	47.90
Others	0.00	0.00	0.00	0.00	0.00
Others	0.00	0.00	0.00	0.00	0.00